These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 11187951)

  • 21. Effective platelet inhibition by aspirin and clopidogrel: where are we now?
    Tousoulis D; Briasoulis A; Dhamrait SS; Antoniades C; Stefanadis C
    Heart; 2009 May; 95(10):850-8. PubMed ID: 19401288
    [No Abstract]   [Full Text] [Related]  

  • 22. [Acetylsalicylic acid for the primary prevention of cardiovascular disease in diabetic patients].
    de Lange DW; Fiets WE; Banga JD
    Ned Tijdschr Geneeskd; 2004 Jul; 148(30):1481-5. PubMed ID: 15481570
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Risks and benefits of combining aspirin with anticoagulant therapy in patients with atrial fibrillation: an exploratory analysis of stroke prevention using an oral thrombin inhibitor in atrial fibrillation (SPORTIF) trials.
    Flaker GC; Gruber M; Connolly SJ; Goldman S; Chaparro S; Vahanian A; Halinen MO; Horrow J; Halperin JL;
    Am Heart J; 2006 Nov; 152(5):967-73. PubMed ID: 17070169
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The potential role of prasugrel in secondary prevention of ischemic events in patients with acute coronary syndromes.
    Toth PP
    Postgrad Med; 2009 Jan; 121(1):59-72. PubMed ID: 19179814
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Challenging the conclusions drawn in "Thrombolysis for acute myocardial infarction: drug review".
    Howlett M
    MedGenMed; 2002 Feb; 4(1):6; author reply 7. PubMed ID: 11965208
    [No Abstract]   [Full Text] [Related]  

  • 26. Aspirin in cardiology--benefits and risks.
    Björklund L; Wallander MA; Johansson S; Lesén E
    Int J Clin Pract; 2009 Mar; 63(3):468-77. PubMed ID: 19222632
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Is there less benefit from warfarin in diabetics after myocardial infarction? The numbing complexities of assessing anticoagulant and antiplatelet therapy in the diabetic patient.
    Smith DA
    Cardiology; 2008; 111(3):158-60. PubMed ID: 18434718
    [No Abstract]   [Full Text] [Related]  

  • 28. Platelet function and response to aspirin: gender-specific features and implications for female thrombotic risk and management.
    Zuern CS; Lindemann S; Gawaz M
    Semin Thromb Hemost; 2009 Apr; 35(3):295-306. PubMed ID: 19452405
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Aspirin for first-line heart attack prevention. These is still no consensus; the benefits must be weighed against the risks.
    Duke Med Health News; 2014 Nov; 20(11):5-6. PubMed ID: 25481928
    [No Abstract]   [Full Text] [Related]  

  • 30. Platelet inhibitors: what are the data in women?
    Tempelhof MW; Newby LK
    Cardiol Rev; 2008; 16(1):23-9. PubMed ID: 18091399
    [TBL] [Abstract][Full Text] [Related]  

  • 31. May aspirin be replaced in the treatment of myocardial infarction?
    Bayés de Luna A
    Eur Heart J; 2000 Mar; 21(6):430-2. PubMed ID: 10681480
    [No Abstract]   [Full Text] [Related]  

  • 32. Use of dipyridamole in patients with recent stroke or TIA.
    Bernstein RA
    Am Fam Physician; 2005 Aug; 72(3):382, 384; author reply 384. PubMed ID: 16100852
    [No Abstract]   [Full Text] [Related]  

  • 33. [Thrombolytic therapy of ischemic heart disease].
    Ishikawa K
    Nihon Naika Gakkai Zasshi; 1997 Sep; 86(9):1621-4. PubMed ID: 9410971
    [No Abstract]   [Full Text] [Related]  

  • 34. Combination antithrombotic therapy with antiplatelet agents and anticoagulants for patients with atherosclerotic heart disease.
    Arjomand H; Cohen M; Ezekowitz MD
    J Invasive Cardiol; 2004 May; 16(5):271-8. PubMed ID: 15152137
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Aspirin in the prevention of cardiovascular disease in women.
    Schwartz DJ
    N Engl J Med; 2005 Jun; 352(26):2751-2; author reply 2751-2. PubMed ID: 15987927
    [No Abstract]   [Full Text] [Related]  

  • 36. AHA/ADA vs. ESC/EASD recommendations on aspirin as a primary prevention strategy in people with diabetes: how the same data generate divergent conclusions.
    Nicolucci A; De Berardis G; Sacco M; Tognoni G
    Eur Heart J; 2007 Aug; 28(16):1925-7. PubMed ID: 17604291
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Aspirin study refocuses prevention message for women. Aspirin therapy does less than anticipated in preventing heart attacks in women--but more than we knew in warding off strokes.
    Harv Womens Health Watch; 2005 May; 12(9):1-3. PubMed ID: 16044565
    [No Abstract]   [Full Text] [Related]  

  • 38. Aspirin + clopidogrel therapy: how does your care compare to the evidence?
    Simmons BB; Salzman BE
    J Fam Pract; 2008 Jan; 57(1):26-32. PubMed ID: 18171566
    [No Abstract]   [Full Text] [Related]  

  • 39. Translational therapeutics at the platelet vascular interface. Summary.
    FitzGerald GA
    Arterioscler Thromb Vasc Biol; 2008 Mar; 28(3):s51-2. PubMed ID: 18296588
    [No Abstract]   [Full Text] [Related]  

  • 40. Rationale, design and organization of the Second Chinese Cardiac Study (CCS-2): a randomized trial of clopidogrel plus aspirin, and of metoprolol, among patients with suspected acute myocardial infarction. Second Chinese Cardiac Study (CCS-2) Collaborative Group.
    Second Chinese Cardiac Study (CCS-2) Collaborative Group
    J Cardiovasc Risk; 2000 Dec; 7(6):435-41. PubMed ID: 11189013
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.